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Abstract: Introduction:Compared to ordinary people, addicts usually have a lower pain threshold. The current work at-
tempts to compare the performance of local analgesia with lidocaine among opium addicts and non-addicts.
Methods:In this case-control study, opium addicts and healthy patients with skin laceration referring to emer-
gency departments of two educational hospitals were compared regarding the response to local anesthesia with
lidocaine, as well as side effects. Results: 197 cases with the mean age of 43.44 ± 20.12 years were studied (72.1%
male). 98 (49.8%) cases were addicts and 99 (50.2%) were healthy people. Two groups were similar regarding
age (p = 0.281), sex (p = 0.666), and wound size (p = 0.272). The amount of pain reduction 5 (df =1.5, F=0.38, p
= 0.88) and 10 (df =1.5, F=0.58, p = 0.72) minutes after lidocaine injection was not different between the groups.
Subgroup analysis based on sex and age of patient did not show any differences between the groups (p > 0.1 for
all analysis). The mean duration of analgesia was 16.4 ± 5.37 minutes in addicts and 16.95±1.79 in control group
(p = 0.334). Conclusion: Lidocaine, as a commonly used local anesthetic agents, does not show different effects
in addicts and non-addicts in repairing skin laceration.
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1. Introduction
F
or decades, a new field of worry has been raised in
surgery, which is about people who have drug depen-
dence, especially in cases of intravenous drug use (1,
2). Acute pain would be partially relieved or not relieved at all
among drug users (3). Compared to ordinary people, addicts
usually have a lower pain threshold. Opium addicts have
changes in function, sensitivity, reduction, and/or decreased
number of opioid receptors systematically (4). This is why
addicts are more resistant to analgesia and narcotics used
(5-7). Studies have shown the fact that addicted people ex-
perience shorter anesthesia or sedation duration and depth
when compared to non-addicts (7, 8). This fact has encour-
aged researchers to try to provide routes to use supplemen-
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tary drugs in order to alleviate patients’ pain throughout the
procedures (4).The prevalence of addiction to narcotics was
2.26% in 2011, according to reports by the United Nations Of-
fice on Drugs and Crime (UNODC). Furthermore, Iran is in
the second place of narcotic consumption, worldwide (avail-
able on: http://www.unodc.org).
The current work attempts to compare the performance of
local analgesia with lidocaine among opium addicts and
non-addicts regarding the rate of pain reduction and side ef-
fects.
2. Methods
2.1. Study design and setting
In this case-control study, patients with skin laceration who
were referred to emergency departments of two hospitals af-
filiated to Shahid Beheshti University of Medical Sciences
(Imam Hossein and Shohadaye Tajrish Hospitals) were en-
rolled. Addicted patients were compared with non-addicts in
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Table 1: Baseline characteristics of studied patients
Variables Case (n=98) Control (n= 99) P
Sex
Male 72 (73.5%) 70 (70.7%) 0.666
Female 26 (26.5%) 29 (29.3%)
Age
Mean ± SD 44.95±20.52 41.84±19.87 0.281
Wound size
Mean ± SD 5.81±0.90 5.86±1.01 0.272
Systolic blood pressure (mmHg)
Baseline 125.30±11.51 118.87±13.70 <0.001
30 min 122.86±9.82 118.74±8.20 <0.001
Diastolic blood pressure (mmHg)
Baseline 80.46±5.52 87.08±72.40 0.863
30 minute 79.66±2.83 79.85±1.12 0.420
Pulse rate
Baseline 81.45±8.49 79.70±5.40 0.321
30 minute 81.53±9.44 79.71±5.95 0.344
O2 saturation
Baseline 95.94±1.69 96.94±1.02 <0.001
30 minute 95.04±9.73 103.11±60.41 <0.001
Pain score
Baseline 6.1±1.4 5.4±1.0 <0.001
5 minute 4.04±1.76 3.00±1.26 <0.001
10 minute 2.00±2.12 1.43±0.72 0.034
Duration of anesthesia
Mean ± SD 16.40±5.38 16.96±1.80 0.003
Median (IQR) 16 (14-18) 17 (16-18)
SD: standard deviation, IQR: Inter-quartile range.
terms of response to anesthesia with local lidocaine, as well
as side effects. The participants gave their informed consents
verbally and all the cases and included data were kept by the
principal investigator to maintain patients’ privacy. People
were free to decide to stay in the study or leave in any step
with no penalty.
2.2. Participants
Patients 15 years of age or older with laceration size of more
than 5cm, were divided into two groups of addicts and non-
addicts. People with any sensory or mental disorder who
have limitations to reliably express their pain severity as well
as cases with tendon injury or positive history of allergic re-
action to lidocaine or cardiac problems were excluded.
Participants were defined as addict when they had used opi-
oids daily for the last 6 months, and had shown withdrawal
symptoms.
2.3. Data gathering
A checklist consisting of demographic data (age, sex), vital
signs (blood pressure, respiratory rate, O2 saturation) before
and 30 minutes after local anesthesia, pain score at 0, 5, and
10 minutes after local anesthesia, as well as duration of anes-
thesia was filled for all case (addicts) and control (healthy)
group members by a senior emergency medicine resident.
2.4. Procedure
Wounds underwent complete sterilization using sterile med-
ical equipment and detergents. Local anesthesia was applied
by injecting subcutaneous lidocaine 2% solution (maximum
dose of 5 mg/kg) at the laceration site after asking the partic-
ipants about their relevant medical background like any al-
lergy to the medication or any cardiologic problems.
Using numeric rating scale (NRS), the pain severity of pa-
tients was recorded before and 5 and 10 minutes after injec-
tion of local lidocaine (the maximum dose of 5 mg/kg). NRS
ranges between 0 and 10, where the former shows no pain,
while a score of 10 shows the highest level of pain, which was
not experienced by the patients.
2.5. Statistical Analysis
The data were entered to SPSS11 for windows, while quan-
titative variables were shown by mean ± standard deviation
and qualitative ones were reported using frequency. Inde-
pendent t-test was used to compare quantitative data, while
Chi-square test was used for qualitative ones. Since systolic
blood pressure (SBP), arterial O2 saturation and pain score
differed between the groups before lidocaine administration;
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Figure 1: Comparing the trend of pain reduction 5 (p = 0.88) and 10
(p = 0.72) minutes after lidocaine injection between case and control
groups.
analysis of covariance was used to compare the findings after
intervention. Effects of age and sex on lidocaine efficacy were
investigated via two-way ANOVA. P value <0.05 was consid-
ered as significance level.
3. Results
3.1. Baseline characteristics
197 cases with the mean age of 43.44 ± 20.12 (16-90) years
were studied (72.1% male). 98 (49.8%) cases were addicts
(case group) and 99 (50.2%) were healthy people (control
group). Table 1 compares the baseline characteristics of stud-
ied groups. The two groups were similar regarding age (p =
0.281), sex (p = 0.666), and wound size (p = 0.272). Pain score
at the time of admission was 6.1 ± 1.4 in addicts and 5.4 ± 1.0
in control group (P<0.001, clinically not important).
3.2. Pain management
Figure 1 compares the trend of pain reduction between the
groups, 5 and 10 minutes after lidocaine injection. The rate
of pain reduction 5 (df =1.5, F=0.38, p = 0.88) and 10 (df =1.5,
F=0.58, p = 0.72) minutes after lidocaine injection was not
different between groups. Subgroup analysis based on sex
and age of patients did not show any differences between the
groups regarding the trend of pain reduction after 5 and 10
minutes (p > 0.1 for all analyses).
The mean duration of analgesia was 16.4 ± 5.37 minutes in
addicts and 16.95±1.79 minutes in control group (p = 0.334).
Although differences of vital signs between groups 30 min-
utes after lidocaine injection were statistically significant,
they were clinically important (table 1).
4. Discussion
The current study disclosed no difference in pain reduction
rate among addict and non-addict participants after using li-
docaine as an anesthetic agent for skin laceration. The dura-
tion of action was similar in case and control groups.
Through a study in Iran, which was done between 2010 and
2011, investigators found that in people with fractured lower
limb, duration of anesthesia was shorter among opium ad-
dicts compared to non-addicts when spinal anesthesia was
tried (4). They also believed that use of multiple medications
or higher doses of anesthetics was required in drug users,
mainly because of their absolute tolerance to the medication.
Narcotics can influence numerous receptors in central and
peripheral parts of nervous system (6, 9). These receptors
would interrupt local anesthesia due to being interfered by
opioids (10, 11).
The current study tried to match age and sex between case
and control groups. However, previous studies have pointed
out that age and body characteristics like weight and height
usually have no impact on anesthesia onset and duration (4).
Regarding the changes in vital signs and O2 saturation, there
was not any clinically significant difference between the
groups. Most adverse side effects of anesthetic medications
are known to manifest in heart and nervous system. The
first report of tonic effects of long-acting local anesthetics on
heart and brain was provided by Albright (12).
In terms of cardiac adverse effects, plasma concentration of
lidocaine with less than 5mg/ml dose has no toxicity on hu-
man heart. In higher serum levels, hypotension would be
a cause of worry. Cardiac toxicity mainly results from car-
diac sodium channel blockage and calcium and potassium
ion channels are also affected, particularly in high doses of
lidocaine and other similar drugs (13). Bradycardia in addi-
tion to hypotension, would lead the patient to hypoxia and
hypercarbia, resulting in acidosis. Acidosis, in turn, could re-
sult in more toxicity by decreasing plasma protein binding of
lidocaine (14, 15). These were the main events checked in the
current study.
Maximum dose for local injection of lidocaine to be safe is
500-600 mg, which is equal to 7-8 mg/kg. In this study, we
used 5mg/kg of the drug for both cases and controls to pre-
vent any serious or permanent side effects.
This study evaluated the consequences of lidocaine admin-
istration, and it seems useful to carry out future researches,
with a bigger sample size from different races, to achieve re-
liable findings in this regard.
5. Conclusion
It could be concluded that lidocaine, as a commonly used lo-
cal anesthetic agent, does not show different effects in ad-
dicts and non-addicts in repairing the skin laceration.
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